Niacin: all 110 studies that test it
Page 1 of 2. Open to participants first (10), then studies with results posted, then the rest; newest registration first within each.
- Clinical Trial on the Protective Role of Vitamin B3 in Enhancing Immunotherapy for Bladder Cancer PatientsRecruitingNCT07119996Phase 1
- The Kidney's Response to Exercise in Heat, and the Impact of Vitamin B3 on This ResponseRecruitingNCT06983730Early Phase 1
- Stimulating Fat Tissue Storage With Niacin to Reduce Fat Accumulation in the Liver.RecruitingNCT06843148Not applicable
- Nicotinic Acid for the Treatment of Alzheimer's DiseaseRecruitingNCT06582706Phase 1/2
- Study the Effect of Niacin on Lipoprotein (a) Concentration and Hyperphosphatemia in Hemodialysis PatientsEnrolling by invitationNCT06406140Phase 2/3
- A Study of Niacin RegulationRecruitingNCT06175403Early Phase 1
- Adipose Tissue Storage in the Rapid Remission of Hepatic and Cardiac Metabolic Dysfunction After Bariatric SurgeryRecruitingNCT05934409Not applicable
- 5-HT2A Agonist Psilocybin in the Treatment of Tobacco Use DisorderRecruitingNCT05452772Phase 2
- Pathways of Eicosanoid MetabolismEnrolling by invitationNCT04464070Early Phase 1
- Regulation of Endogenous Glucose Production by Central KATP ChannelsRecruitingNCT03540758Phase 2
- Effects of Niacin on Intramyocellular Fatty Acid Trafficking in Upper Body Obesity and Type 2 Diabetes MellitusCompletedNCT03867500Early Phase 1Results posted
- Low Dose Niacin (Vitamin B3) for Parkinson's DiseaseTerminatedNCT03808961Not applicableResults posted
- An Efficacy and Safety Study of Alirocumab in Children and Adolescents With Heterozygous Familial HypercholesterolemiaCompletedNCT03510884Phase 3Results posted
- An Efficacy and Safety Study of Alirocumab in Children and Adolescents With Homozygous Familial HypercholesterolemiaCompletedNCT03510715Phase 3Results posted
- GPR109A and Parkinson's Disease: Role of Niacin in Outcome MeasuresCompletedNCT03462680Not applicableResults posted
- An 8-Week Dose-Finding Study to Evaluate the Efficacy and Safety of Alirocumab in Children and Adolescents With Heterozygous Familial HypercholesterolemiaCompletedNCT02890992Phase 2Results posted
- Effects of Niacin Therapy on Lipoprotein Composition and FunctionCompletedNCT02322203Not applicableResults posted
- Assessment Of Vascular Health After Niacin Therapy (AVANT)CompletedNCT02003638Not applicableResults posted
- Endothelial Function, Lipoproteins, and Inflammation With Low HDL Cholesterol in HIV: ER Niacin Versus FenofibrateCompletedNCT01426438Phase 2Results posted
- Niacin/Laropiprant Tablet for South and Southeast Asians With Low High-Density Lipoprotein Cholesterol (LDL-C) at Risk for Cardiovascular Disease (MK-0524A-108)TerminatedNCT01414166Phase 3Results posted
- Effect of Niacin on Transport of HDL and Relationship to Atherogenic Lipoproteins and LipolysisCompletedNCT01250990Not applicableResults posted
- Effect of Niacin/Laropiprant on Postprandial Lipoprotein Metabolism in Patients With DyslipoproteinemiaTerminatedNCT01239992Phase 4Results posted
- Novel Pathways to Manage Inflammation and Atherosclerosis in Dialysis Patients: Role of Nicotinic AcidTerminatedNCT01159054Not applicableResults posted
- A Study to Evaluate the Effects of Laropiprant on the Antiplatelet Effects of Clopidogrel and Aspirin in Combination (MK-0524A-114)(COMPLETED)CompletedNCT01012219Phase 1Results posted
- Study of Niacin on Endothelial Function in HIV-infected Subjects With Low High Density Lipoprotein Cholesterol LevelsCompletedNCT00986986Not applicableResults posted
- The Genetics of Evoked Responses to Niacin and Endotoxemia: The GENE StudyCompletedNCT00953667Not applicableResults posted
- Niacin and Endothelial Function in Early CKDCompletedNCT00852969Phase 4Results posted
- Merck Carotid Atherosclerosis Trial (MK-0000-111)(COMPLETED)CompletedNCT00804843Phase 2Results posted
- Randomized, Controlled Trial of Extended-Release Niacin (Niaspan®) to Augment Subacute Ischemic Stroke RecoveryTerminatedNCT00796887Phase 2Results posted
- A Study to Evaluate the Effects of Extended Release (ER) Niacin/Laropiprant, Laropiprant, ER Niacin, and Placebo on Urinary Prostanoid Metabolites in Subjects With High Cholesterol (0524A-075)(COMPLETED)CompletedNCT00769132Phase 1Results posted
- Combined Effects of Non-statin Treatments on Apolipoprotein A-I Up-Regulation (CENTAUR): A Feasibility StudyCompletedNCT00728910Phase 2Results posted
- Evaluate Carotid Artery Plaque Composition by Magnetic Resonance Imaging in People Receiving Cholesterol MedicationCompletedNCT00715273Phase 4Results posted
- Effectiveness of Intensive Lipid Modification Medication in Preventing the Progression of Peripheral Arterial Disease (The ELIMIT Study)CompletedNCT00687076Phase 4Results posted
- Evaluation of a Flushing ASsessment Tool (FAST) in Subjects Receiving Niacin Extended-release Plus AspirinCompletedNCT00630877Phase 3Results posted
- Effect of MK0524A on Cholesterol Levels (0524A-048)CompletedNCT00536510Phase 3Results posted
- Retrospective Study of the Effectiveness and Safety of Niacin and Steroid Eye Drops for Retinal Vein OcclusionsTerminatedNCT00500045Phase 2/3Results posted
- To Study the Effectiveness and Safety of Niacin and a Topical Steroid Eye Drop to Treat Retinal Vein OcclusionsCompletedNCT00493064Phase 2/3Results posted
- Study of Extended Release Niacin/Laropiprant on Lipids (0524A-067)CompletedNCT00479388Phase 3Results posted
- An Open-Label Study to Compare the Lipid Effects of Niacin ER and Simvastatin (NS) to Atorvastatin in Subjects With Hyperlipidemia or Mixed Dyslipidemia (SUPREME)CompletedNCT00465088Phase 3Results posted
- Treatment of HDL to Reduce the Incidence of Vascular Events HPS2-THRIVECompletedNCT00461630Phase 3Results posted
- Niacin, N-3 Fatty Acids and Insulin ResistanceCompletedNCT00286234Phase 4Results posted
- To Evaluate Ezetimibe/Simvastatin and Niacin (Extended Release Tablet) in Patients With Type IIa or Type IIb Hyperlipidemia (0653A-091)(COMPLETED)CompletedNCT00271817Phase 3Results posted
- Obesity and Nonalcoholic Fatty Liver DiseaseCompletedNCT00262964Not applicableResults posted
- Diet, Exercise, Niacin, and Fenofibrate to Reduce Heart Disease Risk Factors in Individuals With HIV Lipodystrophy or DyslipidemiaCompletedNCT00246376Not applicableResults posted
- A Prospective, Open Label Comparison of Ezetimibe, Niacin, and Colestipol as Adjunct Therapy in Lipid ReductionCompletedNCT00203476Phase 4Results posted
- High-Density Lipoprotein (HDL) Cholesterol Increased Plaque Stabilization in the ElderlyCompletedNCT00127218Phase 3Results posted
- Niacin Plus Statin to Prevent Vascular EventsTerminatedNCT00120289Phase 3Results posted
- Study of the Use of Niaspan for Treatment of Dyslipidemia in Diabetic NephropathyTerminatedNCT00108485Phase 3Results posted
- Vitamin B12 vs B3 for Nerve Regeneration and Functional Recovery After Pediatric Traumatic Brain InjuryCompletedNCT05958277Phase 3
- Effect of Nicotinic Acid as Add on Therapy in Patients Receiving β Blocker for Prophylaxis of Moderate to Severe MigraineCompletedNCT05846373Phase 2
- Activation of Brown Adipose Tissue Thermogenesis in Humans Using Formoterol Fumarate (GB10)CompletedNCT05553184Not applicable
- Effect of Adjunctive Use of Vitamin B3 and B9 on Myeloperoxidase Level in the GCF of Patients With Stage I and II PeriodontitisStatus unknownNCT05435378Early Phase 1
- Glycogen and AppetiteCompletedNCT05417659Not applicable
- Brown Adipose Tissue Metabolism in Type 2 DiabetesCompletedNCT05092945Not applicable
- Effects of Ketones and Niacin in Heart Failure PatientsCompletedNCT04703361Phase 2
- Study of Niacin in GlioblastomaActive, not recruitingNCT04677049Phase 1/2
- NiaMIT Continuation With Early-stage Mitochondrial Myopathy PatientsCompletedNCT04538521Not applicable
- A Study of Evaluating Dual Inhibitor of PAK4 and NAMPT ATG-019 in Advanced Solid Tumors or Non-Hodgkin's LymphomaTerminatedNCT04281420Phase 1
- A Study to Investigate Nicotinic Acid on VEGFR Inhibitor-Associated Hand-Foot Skin ReactionsStatus unknownNCT04242927Phase 2
- Niacin Supplementation in Healthy Controls and Mitochondrial Myopathy PatientsCompletedNCT03973203Not applicable
- Effects of Vitamin B3 in Patients With Ataxia TelangiectasiaCompletedNCT03962114Phase 2
- Nutritional Supplements and Performance During Visual Field Testing (B3 Vitamin)CompletedNCT03797469Not applicable
- The Role of Hepatic Denervation in the Dysregulation of Glucose Metabolism in Liver Transplant RecipientsWithdrawnNCT03685773Phase 2
- The Efficacy of Niacin on Hyperphosphatemia in Patients Undergoing HaemodialysisStatus unknownNCT03163576Phase 4
- Postprandial Fatty Acid Metabolism in the Natural History of Type 2 Diabetes (T2D)CompletedNCT02808182Not applicable
- Characterization of High Density Lipoprotein (HDL) in Type 2 Diabetes (T2D) After Fenofibrate or Niacin TreatmentCompletedNCT02153879Phase 4
- Early Aortic Valve Lipoprotein(a) Lowering TrialWithdrawnNCT02109614Early Phase 1
- Niacin on Immune Activation : a Proof-of-concept StudyCompletedNCT02018965Phase 2
- Effects of Niacin On Fatty Acid TrappingCompletedNCT01984073Phase 1
- Short-term Effect of Extended-release Niacin on Endothelial Function.CompletedNCT01942291Phase 4
- Benefit of Elevation of HDL-C in WomenCompletedNCT01921010Phase 4
- Feeding Trial to Determine How Combinations of Different Dietary Bioactive Ingredients Influence High Density Lipoprotein (HDL) MetabolismCompletedNCT01803594Not applicable
- Niapsan as Add -on Therapy to Antipsychotic Treatment in First Episode PsychosisCompletedNCT01720095Phase 3
- ER Niacin/Laropiprant Impact on Cardiovascular Markers and Atheroprogression in HIV-infected Individuals on cARTTerminatedNCT01683656Phase 4
- Nicotinic Acid Composition of HDL and Arterial Endothelium Function in Premature Coronary Heart Disease and High HDLTerminatedNCT01450410Phase 4
- Effects of Niacin on Good Cholesterol in People With Peripheral Arterial DiseaseTerminatedNCT01391377Not applicable
- Effect of Niacin in the Lipoprotein (a) ConcentrationCompletedNCT01321034Phase 4
- Effect of Extended-Release Niacin on Saphenous Vein Graft AtherosclerosisCompletedNCT01221402Phase 2
- Niacin/Laropiprant and Endothelial FunctionCompletedNCT01126073Phase 4
- Effect of Nicotinic Acid on Cardiovascular Risks Indices in Polycystic Ovary SyndromeCompletedNCT01118598Phase 4
- A Study of Niaspan on Endothelium-Dependent and Endothelium-Independent Vascular Reactivity (0000-093)CompletedNCT01104519Phase 1
- Effect of Nicotinic Acid on Adipose Tissue Inflammation in Obese SubjectsCompletedNCT01083329Phase 2
- Effects of Niaspan™ on High-density Lipoprotein (HDL) in Healthy Male Subjects (0000-069)CompletedNCT01071291Phase 1
- Effect of Tredaptive on Serum Lipoproteins and Inflammatory MarkersCompletedNCT01054508Phase 4
- The Impact of Tredaptive on Flow-Mediated Dilation in Cardiac PatientsTerminatedNCT01052311Phase 4
- Comparison of High-Dose Rosuvastatin Versus Low Statin Dose Plus Fenofibrate Versus Low Statin Dose Plus Niacin in the Treatment of Mixed HyperlipidemiaStatus unknownNCT01010516Phase 4
- Effects of Nicotinic Acid Plus Simvastatin Versus Simvastatin Alone on Carotid and Femoral Intima-Media Thickness in Patients With Peripheral Artery Disease (NASCIT)Status unknownNCT00712049Phase 4
- Extended Release (ER) Niacin/Laropiprant Add on Study (0524A-082)WithdrawnNCT00664287Phase 3
- Assessment of Interaction Between Vytorin and Niaspan in Healthy Subjects (P04955AM2)CompletedNCT00652431Phase 1
- Evaluation of the Effect of NICOtinic Acid (Niacin) on Elevated Lipoprotein(a) Levels (NICOLa Study)Status unknownNCT00633698Phase 3
- Benefit of Elevation of HDL-C on Cardiovascular Outcomes in WomenCompletedNCT00590629Phase 4
- High-Density Lipoprotein (HDL) Treatment StudyCompletedNCT00458055Not applicable
- Niacin As Secondary Prevention Of Coronary Artery Disease (NASPOCAD)Status unknownNCT00431145Phase 2
- Comparative Study of the Effect of Ezetimibe Versus Extended-Release Niacin on AtherosclerosisTerminatedNCT00397657Phase 4
- Tolerability of MK0524A Versus Niacin Extended-Release (0524A-054)CompletedNCT00378833Phase 3
- Efficacy Study of Extended-Release Niacin/Lovastatin Versus Usual CareCompletedNCT00345657Phase 4
- Study of Niacin and Rosiglitazone in Dysmetabolic DyslipidemiaCompletedNCT00304993Phase 4
- Exercise Versus Niacin in Patients With Coronary Artery Disease (CAD) and Low High-Density Lipoproteins (HDL)CompletedNCT00298909Phase 4
- Lipid Efficacy/Tolerability Study (0524A-020)CompletedNCT00269204Phase 3
- The Low HDL On Six Weeks Statin Therapy (LOW) StudyStatus unknownNCT00238004Phase 4